Alimera Sciences Inc (ALIM):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C2899)
◆英語タイトル:Alimera Sciences Inc (ALIM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2899
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:54
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Alimera Sciences Inc (ALIM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabetic macular edema (DME) in patients who have been previously treated with corticosteroids and did not show any clinically significant increase in intraocular pressure (IOP). Iluvien is also prescribed for treatment of early-and late-stage diseases such as wet and dry age-related macular degeneration (AMD) and retinal vein occlusion. The company distributes its products in France, Austria, Portugal, the Czech Republic, Denmark, Finland, Germany, Spain, the UK and others. Alimera is headquartered in Alpharetta, Georgia, the US.

Alimera Sciences Inc Key Recent Developments

Jul 31,2018: Alimera Sciences Reports Second Quarter 2018 Results
Jun 21,2018: Alimera Sciences Names Mary T. Szela As Board Director
May 23,2018: Plan, plan and plan some more: Alimera’s recipe for social media success
May 02,2018: Alimera Sciences Reports First Quarter 2018 Results
Feb 28,2018: Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Alimera Sciences Inc – Key Facts 6
Alimera Sciences Inc – Key Employees 7
Alimera Sciences Inc – Key Employee Biographies 8
Alimera Sciences Inc – Major Products and Services 9
Alimera Sciences Inc – History 10
Alimera Sciences Inc – Company Statement 11
Alimera Sciences Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Alimera Sciences Inc – Business Description 14
Geographical Segment: International 14
Performance 14
Geographical Segment: Other 14
Performance 14
Geographical Segment: The US 14
Performance 14
R&D Overview 14
Alimera Sciences Inc – Corporate Strategy 15
Alimera Sciences Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Alimera Sciences Inc – Strengths 16
Alimera Sciences Inc – Weaknesses 17
Alimera Sciences Inc – Opportunities 18
Alimera Sciences Inc – Threats 19
Alimera Sciences Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Alimera Sciences Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Jul 31, 2018: Alimera Sciences Reports Second Quarter 2018 Results 30
Jul 31, 2018: Alimera Sciences Reports Second Quarter 2018 Results 32
Jul 31, 2018: Alimera Sciences Reports Second Quarter 2018 Results 34
Jul 31, 2018: Alimera Sciences Reports Second Quarter 2018 Results 36
May 02, 2018: Alimera Sciences Reports First Quarter 2018 Results 38
Feb 28, 2018: Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results 40
Nov 01, 2017: Alimera Sciences Reports Third Quarter 2017 Financial Results 42
Aug 02, 2017: Alimera Sciences Reports Second Quarter 2017 Financial Results 44
May 08, 2017: Alimera Sciences Reports First Quarter 2017 Financial Results 46
Mar 01, 2017: Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results 48
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Alimera Sciences Inc, Key Facts 6
Alimera Sciences Inc, Key Employees 7
Alimera Sciences Inc, Key Employee Biographies 8
Alimera Sciences Inc, Major Products and Services 9
Alimera Sciences Inc, History 10
Alimera Sciences Inc, Subsidiaries 12
Alimera Sciences Inc, Key Competitors 20
Alimera Sciences Inc, Ratios based on current share price 21
Alimera Sciences Inc, Annual Ratios 22
Alimera Sciences Inc, Annual Ratios (Cont...1) 23
Alimera Sciences Inc, Interim Ratios 25
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Alimera Sciences Inc, Recent Deals Summary 29
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53

List of Figures
Alimera Sciences Inc, Performance Chart (2013 - 2017) 24
Alimera Sciences Inc, Ratio Charts 26
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Alimera Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Alimera Sciences Inc (ALIM):企業の財務・戦略的SWOT分析(Alimera Sciences Inc (ALIM) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆